Cargando…

Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1

Mal d 1 is the primary apple allergen in northern Europe. To explain the differences in the allergenicity of apple varieties, it is essential to study its properties and interaction with other phytochemicals, which might modulate the allergenic potential. Therefore, an optimized production route fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaeswurm, Julia A. H., Nestl, Bettina, Richter, Sven M., Emperle, Max, Buchweitz, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838873/
https://www.ncbi.nlm.nih.gov/pubmed/33375510
http://dx.doi.org/10.3390/mps4010003
_version_ 1783643279988883456
author Kaeswurm, Julia A. H.
Nestl, Bettina
Richter, Sven M.
Emperle, Max
Buchweitz, Maria
author_facet Kaeswurm, Julia A. H.
Nestl, Bettina
Richter, Sven M.
Emperle, Max
Buchweitz, Maria
author_sort Kaeswurm, Julia A. H.
collection PubMed
description Mal d 1 is the primary apple allergen in northern Europe. To explain the differences in the allergenicity of apple varieties, it is essential to study its properties and interaction with other phytochemicals, which might modulate the allergenic potential. Therefore, an optimized production route followed by an unsophisticated purification step for Mal d 1 and respective mutants is desired to produce sufficient amounts. We describe a procedure for the transformation of the plasmid in competent E. coli cells, protein expression and rapid one-step purification. r-Mal d 1 with and without a polyhistidine-tag are purified by immobilized metal ion affinity chromatography (IMAC) and fast-protein liquid chromatography (FPLC) using a high-resolution anion-exchange column, respectively. Purity is estimated by SDS-PAGE using an image-processing program (Fiji). For both mutants an appropriate yield of r-Mal d 1 with purity higher than 85% is achieved. The allergen is characterized after tryptic in gel digestion by peptide analyses using HPLC-MS/MS. Secondary structure elements are calculated based on CD-spectroscopy and the negligible impact of the polyhistidine-tag on the folding is confirmed. The formation of dimers is proved by mass spectrometry and reduction by DTT prior to SDS-PAGE. Furthermore, the impact of the freeze and thawing process, freeze drying and storage on dimer formation is investigated.
format Online
Article
Text
id pubmed-7838873
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78388732021-01-28 Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1 Kaeswurm, Julia A. H. Nestl, Bettina Richter, Sven M. Emperle, Max Buchweitz, Maria Methods Protoc Protocol Mal d 1 is the primary apple allergen in northern Europe. To explain the differences in the allergenicity of apple varieties, it is essential to study its properties and interaction with other phytochemicals, which might modulate the allergenic potential. Therefore, an optimized production route followed by an unsophisticated purification step for Mal d 1 and respective mutants is desired to produce sufficient amounts. We describe a procedure for the transformation of the plasmid in competent E. coli cells, protein expression and rapid one-step purification. r-Mal d 1 with and without a polyhistidine-tag are purified by immobilized metal ion affinity chromatography (IMAC) and fast-protein liquid chromatography (FPLC) using a high-resolution anion-exchange column, respectively. Purity is estimated by SDS-PAGE using an image-processing program (Fiji). For both mutants an appropriate yield of r-Mal d 1 with purity higher than 85% is achieved. The allergen is characterized after tryptic in gel digestion by peptide analyses using HPLC-MS/MS. Secondary structure elements are calculated based on CD-spectroscopy and the negligible impact of the polyhistidine-tag on the folding is confirmed. The formation of dimers is proved by mass spectrometry and reduction by DTT prior to SDS-PAGE. Furthermore, the impact of the freeze and thawing process, freeze drying and storage on dimer formation is investigated. MDPI 2020-12-27 /pmc/articles/PMC7838873/ /pubmed/33375510 http://dx.doi.org/10.3390/mps4010003 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Protocol
Kaeswurm, Julia A. H.
Nestl, Bettina
Richter, Sven M.
Emperle, Max
Buchweitz, Maria
Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1
title Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1
title_full Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1
title_fullStr Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1
title_full_unstemmed Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1
title_short Purification and Characterization of Recombinant Expressed Apple Allergen Mal d 1
title_sort purification and characterization of recombinant expressed apple allergen mal d 1
topic Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838873/
https://www.ncbi.nlm.nih.gov/pubmed/33375510
http://dx.doi.org/10.3390/mps4010003
work_keys_str_mv AT kaeswurmjuliaah purificationandcharacterizationofrecombinantexpressedappleallergenmald1
AT nestlbettina purificationandcharacterizationofrecombinantexpressedappleallergenmald1
AT richtersvenm purificationandcharacterizationofrecombinantexpressedappleallergenmald1
AT emperlemax purificationandcharacterizationofrecombinantexpressedappleallergenmald1
AT buchweitzmaria purificationandcharacterizationofrecombinantexpressedappleallergenmald1